Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Dexmedetomidine (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [15] 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
2 | Dexmedetomidine 1 (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
3 | Dexmedetomidine 2 (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
4 | Dexmedetomidine 3 (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 280 280 💬
|
5 | Dexmedetomidine group (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
6 | Dexmedetomidine HCL 100 MCG/ML INJ (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 215 215 💬
|
7 | Dexmedetomidine hydrochloride | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
8 | Dexmedetomidine hydrochloride infusion | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|
9 | Dexmedetomidine injection (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride) | [2] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [4] Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
10 | Dexmedetomidine with ropivacaine (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [2] Dexmedetomidine Dexmedetomidine (Dexmedetomidine hydrochloride),Ropivacaine | [4] Dexmedetomidine
Dexmedetomidine
,Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE), Ropivacaine hydrochloride , Ropivacaine 💬 | [8] ADRA2A ADRA2A,ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | [1] 70 70 💬
|
11 | Fentanyl (LOW dose) + dexmedetomidine (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [1] Fentanyl Fentanyl | [3] Fentanyl
Fentanyl
,Fentanyl citrate , Fentanyl hydrochloride 💬 | [1] OPRM1 OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 215 215 💬
|
12 | Scopolamine, atropine, edaravone and dexmedetomidine (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) | [2] Edaravone Edaravone,Scopolamine | [2] Scopolamine
Scopolamine
,Edaravone 💬 | [5] CHRM1 CHRM1,CHRM2, CHRM3, CHRM4, CHRM5 💬 | [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 💬
|